Your browser doesn't support javascript.
loading
Metformin and Rifampicin combination augments active to latent tuberculosis conversion: A computational study.
Yadav, Deepak; Kaur, Sumanpreet; Banerjee, Dibyajyoti; Bhattacharyya, Rajasri.
Affiliation
  • Yadav D; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Kaur S; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Banerjee D; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Bhattacharyya R; Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Biotechnol Appl Biochem ; 68(6): 1307-1312, 2021 Dec.
Article in En | MEDLINE | ID: mdl-33059386
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / Latent Tuberculosis / Molecular Docking Simulation / Metformin / Mycobacterium tuberculosis / Antitubercular Agents Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / Latent Tuberculosis / Molecular Docking Simulation / Metformin / Mycobacterium tuberculosis / Antitubercular Agents Limits: Humans Language: En Year: 2021 Type: Article